Mylan announced that the FDA has approved its Abbreviated New Drug Application (ANDA) for Fenofibrate Capsules, the generic of Lupin‘s Antara.

Antara is a fibrate indicated as an adjunct to diet when response to nondrug therapy is inadequate in hypertriglyceridemia (Types IV and V), and to reduce elevated total-C, LDL-C, apo B, and TG, and to increase HDL-C, in primary hypercholesterolemia and mixed dyslipidemia (Type IIa and IIb).

Fenofibrate Capules are available in 43mg and 130mg strengths. Mylan has begun shipping this product.

For more information call (800) RX-MYLAN or visit